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Abstract
Objective
Epidemiological studies relating maternal 25-hydroxyvitamin D (25OHD) with gestational
diabetes mellitus (GDM) and mode of delivery have shown controversial results. We exam-
ined if maternal 25OHD status was associated with plasma glucose concentrations, risks of
GDM and caesarean section in the Growing Up in Singapore Towards healthy Outcomes
(GUSTO) study.
Methods
Plasma 25OHD concentrations, fasting glucose (FG) and 2-hour postprandial glucose
(2HPPG) concentrations were measured in 940 women from a Singapore mother-offspring
PLOSONE | DOI:10.1371/journal.pone.0142239 November 16, 2015 1 / 16
OPEN ACCESS
Citation: Loy SL, Lek N, Yap F, Soh SE, Padmapriya
N, Tan KH, et al. (2015) Association of Maternal
Vitamin D Status with Glucose Tolerance and
Caesarean Section in a Multi-Ethnic Asian Cohort:
The Growing Up in Singapore Towards Healthy
Outcomes Study. PLoS ONE 10(11): e0142239.
doi:10.1371/journal.pone.0142239
Editor: Andrzej T Slominski, University of Alabama at
Birmingham, UNITED STATES
Received: August 4, 2015
Accepted: October 18, 2015
Published: November 16, 2015
Copyright: © 2015 Loy et al. This is an open access
article distributed under the terms of the Creative
Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: Due to an ethical
restriction (patient confidentiality), data are available
upon request to the GUSTO team. Please contact the
GUSTO data team at Chang_Mei_Ling@sics.a-star.
edu.sg to request access to the data.
Funding: This study was supported by the Singapore
National Research Foundation under its Translational
and Clinical Research (TCR) Flagship Programme
and administered by the Singapore Ministry of
Health’s National Medical Research Council (NMRC),
Singapore—NMRC/TCR/004-NUS/2008; NMRC/
cohort study at 26–28 weeks’ gestation. 25OHD inadequacy and adequacy were defined
based on concentrations of 25OHD75nmol/l and >75nmol/l respectively. Mode of delivery
was obtained from hospital records. Multiple linear regression was performed to examine
the association between 25OHD status and glucose concentrations, while multiple logistic
regression was performed to examine the association of 25OHD status with risks of GDM
and caesarean section.
Results
In total, 388 (41.3%) women had 25OHD inadequacy. Of these, 131 (33.8%), 155 (39.9%)
and 102 (26.3%) were Chinese, Malay and Indian respectively. After adjustment for con-
founders, maternal 25OHD inadequacy was associated with higher FG concentrations (β =
0.08mmol/l, 95% Confidence Interval (CI) = 0.01, 0.14), but not 2HPPG concentrations and
risk of GDM. A trend between 25OHD inadequacy and higher likelihood of emergency cae-
sarean section (Odds Ratio (OR) = 1.39, 95% CI = 0.95, 2.05) was observed. On stratifica-
tion by ethnicity, the association with higher FG concentrations was significant in Malay
women (β = 0.19mmol/l, 95% CI = 0.04, 0.33), while risk of emergency caesarean section
was greater in Chinese (OR = 1.90, 95% CI = 1.06, 3.43) and Indian women (OR = 2.41,
95% CI = 1.01, 5.73).
Conclusions
25OHD inadequacy is prevalent in pregnant Singaporean women, particularly among the
Malay and Indian women. This is associated with higher FG concentrations in Malay
women, and increased risk of emergency caesarean section in Chinese and Indian women.
Introduction
Vitamin D inadequacy, which is defined as serum 25-hydroxyvitamin D (25OHD)<75nmol/l
in some studies [1–2] and<50nmol/l in others [2–3], is common among pregnant women and
has become a global public health problem [4]. During pregnancy, the active form of vitamin
D, 1,25-dihydroxyvitamin D (1,25(OH)2D) concentrations increase by 100% or more [5].
Recently, it has been shown that production of 20-hydroxyvitamin D (20OHD) was higher
than 25OHD in placenta [6–7]. However, these hydroxyvitamin D metabolites are not rou-
tinely measured to reflect vitamin D pool of the body. Serum 25OHD which is the major circu-
lating form of vitamin D, is currently used as the best determinant of vitamin D status [5].
Associations have been found between serum 25OHD with various pregnancy outcomes such
as gestational diabetes mellitus (GDM), hyperglycaemia and caesarean section (S1 Table), but
results have been inconclusive.
25OHD involves in glucose homeostasis via different mechanisms. In its active form, it
improves insulin sensitivity of the target cells (liver, skeletal muscle and adipose tissue) [8]. It
also improves β-cell function [9], protects β-cell from immune attacks and reduces insulin
resistant through immunoregulatory and anti-inflammatory effects [8]. Serum 25OHD has
been shown to be inversely associated with maternal fasting glucose [10–14] and postprandial
glucose concentrations [15–16] during pregnancy, but there are conflicting data with respect to
the risk of developing GDM. Some studies have suggested that low serum 25OHD was
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associated with GDM [12–13,16–18], while other studies found no significant associations
with GDM [1,10,15,19–20].
It has been shown that both skeletal and uterine smooth muscle contain vitamin D receptors
[21–22], with more recent data implicating 25OHD and regulation of contractile proteins in
human uterine myometrial cells [23]. The relationship of 25OHD with labour and delivery out-
comes can thus be related to both muscle performance and uterine contraction. Higher likelihood
of caesarean delivery has been observed in pregnant women with low serum 25OHD concentra-
tions [24–25], although this had not been the case in several other studies [1,19,26–27].
Serum 25OHD levels vary according to geographical location and sunlight exposure [28]. In
fact, striking ethnicity disparities in the prevalence of 25OHD deficiency has been reported within
the same country or even city [29–30]. The Third National Health and Nutrition Examination
Survey (NHANES III) in United States found that serum 25OHD levels were inversely associated
with diabetes risk in white, but not black populations [29]. However, an Australian study reported
no association between serum 25OHD and GDM risk in any ethnic subgroups [10]. These studies
between 25OHD, ethnicity and disease outcomes were mainly conducted in Western setting, but
none have been designed to describe the association in a multi-ethnic Asian setting.
The Singapore Growing Up in Singapore Towards healthy Outcomes (GUSTO) study, con-
sisting of mothers from three ethnic groups, namely the Chinese, Malays and Indians, provides
a unique opportunity to evaluate pregnancy outcomes associated with 25OHD status across
ethnic groups with the absence of seasonal variation in sunlight exposure. This study aimed to
examine the association of maternal 25OHD status in the second trimester of pregnancy with
plasma glucose concentrations, risks of GDM and caesarean section. We hypothesized that
25OHD inadequacy was associated with higher fasting glucose (FG) and 2-hour postprandial
glucose (2HPPG) concentrations, increased risks of GDM and emergency caesarean section
due to prolonged labour and foetal distress.
Methods
Study design and participants
Women were drawn from the GUSTO mother-offspring cohort study, which involved detailed
assessment of pregnant women and characteristics of their offspring from birth onwards [31].
The GUSTO study was designed to investigate the effects of early life events on the risk of
developing metabolic diseases in later life. This study was conducted according to the guide-
lines laid down in the Declaration of Helsinki. Ethical approval was obtained from the Domain
Specific Review Board of Singapore National Healthcare Group (reference D/09/021) and the
Centralised Institutional Review Board of SingHealth (reference 2009/280/D).
Pregnant women attending antenatal care (<14 weeks’ gestation) from June 2009 to Sep-
tember 2010 in KKWomen’s and Children’s Hospital (KKH) and National University Hospital
(NUH), which house the major public maternity units in Singapore, were recruited into the
GUSTO study. The inclusion criteria included age range between 18 and 50 years, intention to
reside in Singapore for the next five years, intention to deliver in KKH and NUH, and willing-
ness to donate cord, cord blood and placenta. Only Chinese, Malay and Indian women whose
parents and whose husband’s parents were of same ethnicity were included in the study.
Women receiving chemotherapy, psychotropic drugs or with type 1 diabetes mellitus were
excluded. Informed written consent was obtained from all women.
Data collection
Women recruited in their first trimester returned to the hospitals at 26–28 weeks’ gestation for
a follow-up visit. Detailed interviews were conducted in the clinics at recruitment and at 26–28
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weeks’ gestation. Data on socioeconomic status, educational attainment, personal health, die-
tary supplement intake, smoking status and physical activity were collected. Smoking exposure
was defined as current smoking or exposed to second hand smoke on a daily basis. After deliv-
ery, data on mode of delivery and complications were retrieved from the hospital case notes by
trained health personnel.
Physical activity assessment
Three types of physical activity were assessed, including light-moderate, moderate and vigor-
ous intensity activities. Total level of physical activity was computed from the summation of
the duration (in minutes) and frequency (days) of these three types of activity. Physical activity
was expressed in metabolic equivalents (MET-minutes/week) and classified as not highly active
(<3000 MET-minutes/week) and highly active (3000 MET minutes/week) levels [32].
Anthropometric measurement
Maternal height was measured with a stadiometer (Seca 206, Hamburg, Germany). Maternal
weight was based on body weight measured at first antenatal clinic visit during the first trimes-
ter of pregnancy. Body mass index (BMI) was computed from the formula: weight (kg)/ height
(m2). Because obesity is a risk factor of low 25OHD [5], GDM and caesarean section [33],
we therefore categorized the continuous values of BMI for analysis. The BMI was classified
according to World Health Organization ranges: underweight<18.5kgm-2, normal weight
18.5–24.9kgm-2, overweight 25–29.9kgm-2 and obese30.0kgm-2 [34].
Plasma glucose and 25OHD concentrations
An overnight fasting blood samples were drawn at 26–28 weeks’ gestation for glucose and
25OHD analyses. At the same visit, women underwent 75g Oral Glucose Tolerance Test
(OGTT) for GDM diagnosis using World Health Organization criteria (FG or 2HPPG concen-
trations7.0 or7.8mmol/l respectively) [35]. Plasma FG and 2HPPG concentrations were
measured by colorimetry [Advia 2400 Chemistry system (Siemens Medical Solutions Diagnos-
tics) and Beckman LX20 Pro analyzer (Beckman Coulter)].
Plasma 25OHD was analysed as 25-hydroxyvitamin D2 (25OHD2) and 25-hydroxyvitamin
D3 (25OHD3) by isotope-dilution liquid chromatography–tandem mass spectrometry
(ID-LC-MS/MS) [36]. The intra- and inter-assay CVs for 25OHD2 and 25OHD3 were10.3%,
and the detection limit was<4nmol/l for both metabolites. Women were categorized as having
25OHD inadequacy and 25OHD adequacy based on concentrations of 25OHD75nmol/l
and>75nmol/l respectively [37–38]. The cut-off of 25OHD deficiency at<50nmol/l was not
adopted due to small sample size of pregnant women in this category when stratified by ethnic-
ity, which would reduce the power of analysis (S2 Table).
Statistical analysis
Categorical data were presented as frequencies and percentages, while continuous data were
presented as means and standard deviations. Comparisons between maternal characteristics
and 25OHD status were performed using Pearson’s Chi-square test for categorical variables
and independent t-test for continuous variables. Multiple logistic regression analysis was used
to assess the association of 25OHD status with risks of GDM and caesarean sections (total cae-
sarean section, emergency caesarean section and related indications, and elective caesarean sec-
tion). Multiple linear regression analysis was used to assess the association of 25OHD status
with FG and 2HPPG concentrations.
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Both logistic and linear regression models were adjusted for confounding variables, which
included maternal age, parity, ethnicity, education, body mass index, smoking exposure, physi-
cal activity during pregnancy, and pre-existing diabetes and / or hypertension. These con-
founders were selected based on literature review [25,39–40]. Because neonatal sex has been
reported to be associated with risk of maternal GDM [41–42] and since an association was
found between 25OHD status and neonatal sex (p = 0.036), we therefore further adjusted for
this confounding variable in the final model. All statistical analyses were performed using IBM
SPSS statistics, Version 20 (USA). Two-sided tests were used. A value of P<0.05 was consid-
ered statistically significant.
Results
Of 1152 pregnant women who were recruited in the study at<14 weeks’ gestation, 1087
(94.4%) of them remained until the delivery stage (Fig 1). A total of 940 (86.5%) women with
adequate amount of plasma samples were successfully analysed for 25OHD concentrations. Of
this, 155 women had GDM, 279 women delivered via caesarean section, 183 and 96 women
underwent emergency and elective caesarean sections respectively. Sixty eight women were
delivered by emergency caesarean for a prolonged labour and another 67 for foetal distress.
These two indications together accounted for almost three-quarters (73.8%) of delivery by
emergency caesarean section (Table 1).
Table 1 shows the characteristics of the participants. The mean 25OHD concentration for
all women (n = 940) was 81.0nmol/l (standard deviation = 27.2). A total of 388 (41.3%) women
had 25OHD inadequacy. Compared to women with adequate 25OHD status, this group of
women were younger (p<0.001), comprised of more Malays (p<0.001), heavier (p = 0.008),
attained lower educational levels (p = 0.007), reported higher smoking exposures during preg-
nancy (p = 0.004) and less likely to take vitamin D and calcium supplements during pregnancy
(p<0.001). No significant differences in maternal 25OHD status were observed when analysed
for parity, physical activity and pre-existing diabetes and/ or hypertension. Higher FG concen-
trations were found in women with 25OHD inadequacy compared to those with 25OHD ade-
quacy (p = 0.020). Upon stratification by ethnicity, FG concentrations and incidence of
emergency caesarean sections differed by 25OHD status in only the Malay (p = 0.027) and
Indian women (p = 0.034) (Table 2).
Table 3 presents the associations between 25OHD status and related outcomes before and
after adjusting for potential confounding. Compared to women with adequate 25OHD status,
women with 25OHD inadequacy had higher FG concentrations (β = 0.08mmol/l, 95% Confi-
dence Interval (CI) = 0.02, 0.14). This effect estimate did not change even after adjustment for
confounders (β = 0.08mmol/l, 95% CI = 0.01, 0.14). Women with 25OHD inadequacy showed
a trend towards a higher likelihood of emergency caesarean section in both unadjusted (Odds
Ratio (OR) = 1.32, 95% CI = 0.95, 1.83) and adjusted (OR = 1.39, 95% CI = 0.95, 2.05) models.
The 2HPPG concentrations, GDM and non-emergency caesarean section rates were not found
to be associated with 25OHD status in both unadjusted and adjusted models.
When analyses were stratified by ethnicity (Table 4), the association between inadequate
25OHD status and higher FG concentrations was significant in Malay women (β = 0.19 mmol/l,
95% CI = 0.04, 0.33), but not in Chinese and Indian women, while the odds of having emergency
caesarean section were approximately two times greater in Chinese (OR = 1.90, 95% CI = 1.06,
3.43) and Indian women (OR = 2.41, 95% CI = 1.01, 5.73) with 25OHD inadequacy compared to
those with 25OHD adequacy.
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Discussion
In this multi-ethnic cohort, 41% of pregnant women were found to have inadequate plasma
levels of 25OHD in the second trimester, with substantially higher rates found in Malay and
Indian women compared to Chinese women. Overall, maternal 25OHD inadequacy was signif-
icantly associated with higher FG concentrations, and a trend towards higher likelihood of
emergency caesarean delivery. By ethnicity, the association between inadequate 25OHD status
and higher FG concentrations was found to be significant only in Malay women, while the
odds of having emergency caesarean section were approximately two times greater in Chinese
and Indian women with 25OHD inadequacy. We found no association of maternal 25OHD
status with 2HPPG concentrations, risks of GDM and non-emergency caesarean sections in
the overall cohort as well as within any ethnic group.
Our observation mostly supports the findings of previous studies regarding the association
between 25OHD and glucose metabolism in obstetric populations. In line with previous studies
[10–14], we found an inverse association between 25OHD and FG concentrations, but no asso-
ciation with 2HPPG concentrations was observed [11,13]. This suggests that 2HPPG may be
less likely to be influenced by 25OHD concentrations although its variability is larger than FG.
Fig 1. Study profile.
doi:10.1371/journal.pone.0142239.g001
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The reasons for the lack of an association between 25OHD and 2HPPG are unclear. It has been
reported that 1- and 2-hour postprandial glucose values are largely driven by insulin resistant
state [11]. One possibility is that 25OHDmay not influence glucose metabolism via modula-
tion of insulin sensitivity, but through other pathways such as modulating pancreatic beta-cell
function or cytokines generation [43]. Compared to 2HPPG, FG during pregnancy has been
Table 1. Characteristics of participants according to 25OHD status (n = 940)a.
Characteristics Total (n = 940) 25OHD inadequacy (n = 388) 25OHD adequacy (n = 552) pb
Plasma 25OHD, nmol/l 81.03 (27.18) 55.43 (13.81) 99.02 (18.40) <0.001
Age, years 30.53 (5.11) 29.54 (5.12) 31.24 (4.99) <0.001
Ethnicity, n (%)
Chinese 519 (55.2) 131 (25.2) 388 (74.8) <0.001
Malay 247 (26.3) 155 (62.8) 92 (37.2)
India 174 (18.5) 102 (58.6) 72 (41.4)
Parity, n (%)
Nulliparous 402 (42.8) 162 (40.3) 240 (59.7) 0.599
Multiparous 538 (57.2) 226 (42.0) 312 (58.0)
Body mass index (kg/m-2)
Underweight, n (%) 77 (8.2) 30 (39.0) 47 (61.0) 0.008
Normal weight, n (%) 571 (61.1) 222 (38.9) 349 (61.1)
Overweight, n (%) 186 (19.9) 77 (41.4) 109 (58.6)
Obese, n (%) 100 (10.7) 57 (57.0) 43 (43.0)
Education, n (%)
None/ Primary/ Secondary 284 (30.6) 117 (41.2) 167 (58.8) 0.007
Post-secondary 326 (35.2) 154 (47.2) 172 (52.8)
University and others 317 (34.2) 111 (35.0) 206 (65.0)
Smoking exposure, n (%) 344 (36.8) 163 (42.1) 181 (33.0) 0.004
Intake of supplement containing vitamin D and Calcium, n (%) 635 (74.6) 228 (68.1) 407 (78.9) <0.001
Physical activity, n (%)
Not highly active 746 (80.6) 308 (41.3) 438 (58.7) 0.881
Highly active 179 (19.4) 75 (41.9) 104 (58.1)
Pre-existing diabetes and/ or hypertension, n (%) 19 (2.0) 8 (2.1) 11 (2.0) 0.941
Neonatal sex, n (%)
Boys 489 (52.0) 186 (38.0) 303 (62.0) 0.036
Girls 451 (48.0) 202 (44.8) 249 (55.2)
FG concentrations, mmol/l 4.35 (0.47) 4.39 (0.54) 4.31 (0.42) 0.020
2HPPG concentrations, mmol/l 6.49 (1.44) 6.43 (1.51) 6.53 (1.40) 0.303
GDM, n (%) 155 (17.7) 59 (16.8) 96 (18.3) 0.570
Caesarean section,c n (%) 279 (29.7) 122 (31.4) 157 (28.4) 0.321
Emergency caesarean section, n (%) 183 (21.7) 86 (24.4) 97 (19.7) 0.101
Prolonged labour, n (%) 68 (8.1) 30 (8.5) 38 (7.7) 0.674
Foetal distress, n (%) 67 (7.9) 32 (9.1) 35 (7.1) 0.295
Elective caesarean section, n (%) 96 (10.2) 36 (11.9) 60 (13.2) 0.608
a Total sample size is not always n = 940 due to the missing values. Data are presented as mean (standard deviation) or number (percentage). 25OHD
inadequacy = 25OHD 75nmol/l; 25OHD adequacy = 25OHD>75nmol/l.
b p values are determined by independent t-test or Pearson chi-square test.
c Included both emergency and elective caesarean sections.
25OHD = 25-hydroxyvitamin D; FG = fasting glucose; 2HPPG = 2-hour postprandial glucose; GDM = gestational diabetes mellitus
doi:10.1371/journal.pone.0142239.t001
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shown as a stronger predictor of foetal serum C-peptide levels [44] and adiposity [45], suggest-
ing a potential link between maternal 25OHD inadequacy and impaired metabolic outcomes
in the offspring.
Table 2. Pregnancy outcomes according to 25OHD status and ethnicity.
Variables Chinese (n = 519) Malay (n = 247) Indian (n = 174)
25OHD
inadequacy
(n = 131)
25OHD
adequacy
(n = 388)
pa 25OHD
inadequacy
(n = 155)
25OHD
adequacy
(n = 92)
pa 25OHD
inadequacy
(n = 102)
25OHD
adequacy
(n = 72)
pa
FG concentrations,
mmol/l
4.33 (0.51) 4.31 (0.42) 0.741 4.39 (0.60) 4.25 (0.38) 0.027 4.48 (0.49) 4.39 (0.46) 0.266
2HPPG
concentrations,
mmol/l
6.67 (1.43) 6.60 (1.40) 0.622 6.20 (1.49) 6.20 (1.31) 0.995 6.47 (1.62) 6.59 (1.46) 0.629
GDM 24 (20.0) 75 (20.3) 0.949 14 (9.8) 8 (9.0) 0.839 21 (23.6) 13 (19.4) 0.530
Caesarean
sectionb
42 (32.1) 104 (26.8) 0.247 40 (25.8) 30 (32.6) 0.251 40 (39.2) 23 (31.9) 0.326
Emergency
caesarean
section
27 (23.3) 65 (18.6) 0.276 27 (19.0) 21 (25.3) 0.267 32 (34.0) 11 (18.3) 0.034
Prolonged
labour
10 (8.6) 27 (7.7) 0.760 13 (9.2) 8 (9.6) 0.904 7 (7.4) 3 (5.0) 0.548
Foetal distress 8 (6.9) 21 (6.0) 0.734 14 (9.9) 9 (10.8) 0.814 10 (10.6) 5 (8.3) 0.638
Elective caesarean
section
15 (14.4) 39 (12.1) 0.531 13 (10.2) 9 (12.7) 0.587 8 (11.4) 12 (19.7) 0.191
Data are presented as mean (standard deviation) or number (percentage). 25OHD inadequacy = 25OHD 75nmol/l; 25OHD
adequacy = 25OHD>75nmol/l. The values in bold indicate p<0.05.
a p values are determined by chi-square test or independent t-test.
b Included both emergency and elective caesarean sections.
25OHD = 25-hydroxyvitamin D; FG = fasting glucose; 2HPPG = 2-hour postprandial glucose; GDM = gestational diabetes mellitus.
doi:10.1371/journal.pone.0142239.t002
Table 3. Associations between 25OHD status and pregnancy outcomes.
Crude Adjusted
Maternal outcomes 25OHD adequacy 25OHD inadequacy 25OHD adequacy 25OHD inadequacy
OR (95% CI)a p OR (95% CI)a p
FG concentrations, mmol/l reference 0.08 (0.02, 0.14)b 0.014 Reference 0.08 (0.01, 0.14)b 0.025
2HPPG concentrations, mmol/l reference -0.10 (-0.30, 0.09)b 0.303 Reference 0.05 (-0.15, 0.25)b 0.631
GDM reference 0.90 (0.63, 1.29) 0.571 Reference 1.02 (0.68, 1.53) 0.938
Caesarean sectionc reference 1.15 (0.87, 1.53) 0.322 Reference 1.15 (0.83, 1.58) 0.406
Emergency caesarean section reference 1.32 (0.95, 1.83) 0.102 Reference 1.39 (0.95, 2.05) 0.092
Prolonged labour reference 1.11 (0.68, 1.83) 0.674 Reference 1.24 (0.68, 2.27) 0.480
Foetal distress reference 1.31 (0.79, 2.15) 0.296 Reference 1.08 (0.61, 1.91) 0.788
Elective caesarean section reference 0.89 (0.57, 1.39) 0.608 Reference 0.76 (0.47, 1.24) 0.277
Adjusted for maternal age, parity, ethnicity, education, body mass index, smoking exposure, physical activity, pre-existing diabetes and/ or hypertension,
neonatal sex. 25OHD inadequacy = 25OHD 75nmol/l; 25OHD adequacy = 25OHD>75nmol/l. The values in bold indicate p<0.05.
a Data are presented as Odds Ratio (95% Conﬁdence Interval), unless otherwise indicated.
b Data are presented as β regression coefﬁcient (95% Conﬁdence Interval)
c Included both emergency and elective caesarean sections.
25OHD = 25-hydroxyvitamin D; FG = fasting glucose; 2HPPG = 2-hour postprandial glucose; GDM = gestational diabetes mellitus
doi:10.1371/journal.pone.0142239.t003
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While two previous studies from Australia involving approximately 300 women have
shown an inverse association between 25OHD and FG independent of ethnicity [10–11], we
found that similar to the NHANES III among non-pregnant population [29], ethnicity can
modify the association between 25OHD and glucose metabolism. When ethnic subgroups
were analysed separately, the inverse association between 25OHD and FG only appeared sig-
nificant in Malay women, but not in Chinese and Indian women, suggesting the importance of
vitamin D adequacy to optimise FG concentrations in Malay pregnant women. The inverse
association between 25OHD and FG in Malay women could also be attributable to their rela-
tively higher rates of 25OHD deficiency (25OHD<50nmol/l) compared to other ethnic groups.
However, the contrasting lack of any inverse association of 25OHD with FG in Indian women
was unexpected given their relatively lower 25OHD concentrations and higher FG concentra-
tions. It is possible that this group of Indian women were predisposed to the risk of fasting
hyperglycaemia through pathway which is independent from the influence of 25OHD concen-
trations [10].
The association between serum 25OHD and GDM in the literature is conflicting [46]. In
general, the association between 25OHD and GDMwas more commonly shown in populations
with high prevalence of 25OHD deficiency. In a Turkish study, Zuhur and colleagues [13]
showed significantly lower 25OHD levels in GDM women (n = 234, mean = 30.8nmol/l) than
the controls (n = 168, mean = 36.0nmol/l). However, when subgroups of 25OHD levels were
analysed, only women with severely deficient 25OHD (n = 64,<12.5nmol/l) showed an
increased risk of GDM [13]. Similarly, in a Chinese study of 400 pregnant women with 54%
Table 4. Associations between 25OHD status and pregnancy outcomes according to ethnicity.
Chinese Malay Indian
Pregnancy outcomes 25OHD
adequacy
25OHD inadequacy 25OHD
adequacy
25OHD inadequacy 25OHD
adequacy
25OHD inadequacy
ORa (95% CI) P ORa (95% CI) p ORa (95% CI) p
FG concentrations,
mmol/l
reference 0.03 (-0.06,
0.12)b
0.507 Reference 0.19 (0.04,
0.33)b
0.013 reference 0.09 (-0.07,
0.24)b
0.268
2HPPG concentrations,
mmol/l
reference 0.10 (-0.21,
0.36)b
0.616 Reference 0.12 (-0.24,
0.49)b
0.509 reference 0.08 (-0.42,
0.59)b
0.747
GDM reference 0.92 (0.54,
1.59)
0.771 Reference 1.36 (0.50,
3.72)
0.546 reference 01.34 (0.55,
3.24)
0.520
Caesarean sectionc reference 1.46 (0.91,
2.35)
0.117 Reference 0.67 (0.37,
1.23)
0.194 reference 1.42 (0.70,
2.89)
0.337
Emergency caesarean
section
reference 1.90 (1.06,
3.43)
0.033 Reference 0.56 (0.28,
1.15)
0.115 reference 2.41 (1.01,
5.73)
0.048
Prolonged labour reference 1.91 (0.80,
4.58)
0.146 Reference 0.76 (0.27,
2.14)
0.599 reference 1.50 (0.32,
7.04)
0.608
Foetal distress reference 1.41 (0.55,
3.59)
0.477 Reference 0.73 (0.28,
1.94)
0.533 reference 1.33 (0.33,
5.29)
0.690
Elective caesarean
section
reference 1.02 (0.52,
2.01)
0.948 Reference 0.98 (0.37,
2.61)
0.967 reference 0.35 (0.12,
1.01)
0.052
Adjusted for maternal age, parity, education, body mass index, smoking exposure, physical activity, pre-existing diabetes and/ or hypertension, neonatal
sex. 25OHD inadequacy = 25OHD 75nmol/l; 25OHD adequacy = 25OHD>75nmol/l. The values in bold indicate p<0.05.
a Data are presented as Odds Ratio (95% Conﬁdence Interval), unless otherwise indicated.
b Data are presented as β regression coefﬁcient (95% Conﬁdence Interval)
c Included both emergency and elective caesarean sections.25OHD = 25-hydroxyvitamin D; FG = fasting glucose; 2HPPG = 2-hour postprandial glucose;
GDM = gestational diabetes mellitus.
doi:10.1371/journal.pone.0142239.t004
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25OHD deficiency (<25nmol/l), a significant association between 25OHD at 26–28 weeks’
gestation and risk of developing GDM was found [12]. Similar observations were shown by
other studies which reported a high prevalence (>25%) of vitamin D deficiency with
25OHD<50nmol/l [16–18]. In our cohort, only 0.5% of women had 25OHD<25nmol/l and
13.4% had 25OHD<50nmol/l, and this may explain the lack of association between 25OHD
status and GDM. In fact, several other studies performed in populations where 25OHD defi-
ciency is low [15,20] shared the same finding as ours. We recognized that some of the discrep-
ancies in findings between 25OHD and GDM could also be due to the use of different GDM
diagnosis criteria across studies.
In a cross-sectional study of 253 women, 25OHD<37.5nmol/l measured at birth was associ-
ated with a fourfold increased risk of caesarean section [24]. This finding was replicated by
Scholl et al. [25] who reported a less than twofold (66%) increased risk of caesarean birth for
women with 25OHD<30nmol/l measured at 14 weeks’ gestation. When specific indications
were examined, 25OHD<30nmol/l was linked to a twofold increased risk of caesarean for pro-
longed labour [25]. While our data did not show any significant association between 25OHD
status and total caesarean section, we found that Chinese and Indian women with 25OHD
inadequacy were approximately two times more likely to have emergency caesarean section
than those with 25OHD adequacy. A prospective cohort which studied 995 women in UK
reported no association of 25OHD in the first trimester with emergency or elective caesarean
sections, and related indications such as failure to progress and foetal distress in labour [26].
Similarly, we also did not observe any significant association of 25OHD status with risks of
prolonged labour and foetal distress which could be due to small sample size. These null find-
ings were supported by others [1,19,27]. In these studies, 25OHD assessment was done in early
pregnancy [19,26] and the effect on mode of delivery may become apparent only in late preg-
nancy [26].
The strengths of this study include its prospective study design [31] and the use of liquid
chromatography–tandem mass spectrometry which is a more accurate method compared to
other techniques in measuring 25OHD concentrations [47]. Our study was limited for not
being able to adjust for residual confounding. Only one blood sample during mid-late gestation
was obtained which restricts our ability to evaluate 25OHD concentrations in other windows
that could have had a profound impact on maternal plasma glucose, GDM risk or mode of
delivery. Other pregnancy outcomes such as preeclampsia or infections were not examined due
to their relatively low prevalence rates in our study. A growing body of literature has now docu-
mented an association of genetic variation in cytochrome P450, vitamin D binding protein
[48] and vitamin D receptor [49] with 25OHD concentrations that could impact on vitamin D
metabolism and disease susceptibility. These genetic factors might shed some light in the eth-
nicity susceptibility in the association between 25OHD and different outcome measures. Thus,
assessment of vitamin D related genotype and stratification of cases by both serum levels and
genetic polymorphisms are warranted in future studies.
Conclusions
In conclusion, while prevalence of 25OHD deficiency is low, 25OHD inadequacy is highly
prevalent during pregnancy in Singaporean women, particularly among Malay and Indian
women. This is associated with higher FG concentrations in Malay women and an increased
risk of emergency caesarean section in Chinese and Indian women. This may suggest varying
threshold effects of 25OHD sensitivity on pregnancy outcomes among ethnic groups. Further
investigations on biological components, social, nutritional practices and cultural differences
are required to explain the mechanism of ethnicity disparity in 25OHD effects. Nevertheless,
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the present findings are important to provide evidence for clinical recommendations regarding
potential screening of 25OHD inadequacy during prenatal care and the need for vitamin D
supplementation in at risk groups.
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